0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and China Oligonucleotide API Market Insights, Forecast to 2027
Published Date: November 2021
|
Report Code: QYRE-Auto-34J7553
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global and China Oligonucleotide API Market Insights Forecast to 2027

Global and China Oligonucleotide API Market Insights, Forecast to 2027

Code: QYRE-Auto-34J7553
Report
November 2021
133 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global and China Oligonucleotide API Market
This report focuses on global and China Oligonucleotide API market.
In 2020, the global Oligonucleotide API market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Oligonucleotide API market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Oligonucleotide API Scope and Market Size
Oligonucleotide API market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Oligonucleotide API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Oligonucleotide API market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

Antisense Oligonucleotides API
Small Interfering RNA (siRNA) API
MiRNA API
CpG Oligonucleotides API
Others

Segment by Application

Contract Manufacturing Organizations (CMOs)
Pharmaceutical Companies

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

BY COMPANY

Jazz Pharmaceuticals
Sarepta Therapeutics
Biogen
Dynavax Technologies
Akcea Therapeutics
Alnylam Pharmaceuticals
Nitto Denko (Avecia)
Ajinomoto (GeneDesign)
RiboBio
1 Study Coverage
1.1 Oligonucleotide API Product Introduction
1.2 Market by Type
1.2.1 Global Oligonucleotide API Market Size Growth Rate by Type
1.2.2 Antisense Oligonucleotides API
1.2.3 Small Interfering RNA (siRNA) API
1.2.4 MiRNA API
1.2.5 CpG Oligonucleotides API
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oligonucleotide API Market Size Growth Rate by Application
1.3.2 Contract Manufacturing Organizations (CMOs)
1.3.3 Pharmaceutical Companies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oligonucleotide API Market Size, Estimates and Forecasts
2.1.1 Global Oligonucleotide API Revenue 2016-2027
2.1.2 Global Oligonucleotide API Sales 2016-2027
2.2 Global Oligonucleotide API, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Oligonucleotide API Historical Market Size by Region (2016-2021)
2.3.1 Global Oligonucleotide API Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Oligonucleotide API Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Oligonucleotide API Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Oligonucleotide API Sales Forecast by Region (2022-2027)
2.4.2 Global Oligonucleotide API Revenue Forecast by Region (2022-2027)
3 Global Oligonucleotide API Competitor Landscape by Players
3.1 Global Top Oligonucleotide API Manufacturers by Sales
3.1.1 Global Oligonucleotide API Sales by Manufacturer (2016-2021)
3.1.2 Global Oligonucleotide API Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Oligonucleotide API Manufacturers by Revenue
3.2.1 Key Oligonucleotide API Manufacturers Covered: Ranking by Revenue
3.2.2 Global Oligonucleotide API Revenue by Manufacturers (2016-2021)
3.2.3 Global Oligonucleotide API Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Oligonucleotide API Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Oligonucleotide API Revenue in 2020
3.2.6 Global Oligonucleotide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Oligonucleotide API Price by Manufacturers
3.4 Global Oligonucleotide API Manufacturing Base Distribution, Product Types
3.4.1 Oligonucleotide API Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oligonucleotide API Product Type
3.4.3 Date of International Manufacturers Enter into Oligonucleotide API Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Oligonucleotide API Market Size by Type (2016-2021)
4.1.1 Global Oligonucleotide API Sales by Type (2016-2021)
4.1.2 Global Oligonucleotide API Revenue by Type (2016-2021)
4.1.3 Oligonucleotide API Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Oligonucleotide API Market Size Forecast by Type (2022-2027)
4.2.1 Global Oligonucleotide API Sales Forecast by Type (2022-2027)
4.2.2 Global Oligonucleotide API Revenue Forecast by Type (2022-2027)
4.2.3 Oligonucleotide API Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Oligonucleotide API Market Size by Application (2016-2021)
5.1.1 Global Oligonucleotide API Sales by Application (2016-2021)
5.1.2 Global Oligonucleotide API Revenue by Application (2016-2021)
5.1.3 Oligonucleotide API Price by Application (2016-2021)
5.2 Oligonucleotide API Market Size Forecast by Application (2022-2027)
5.2.1 Global Oligonucleotide API Sales Forecast by Application (2022-2027)
5.2.2 Global Oligonucleotide API Revenue Forecast by Application (2022-2027)
5.2.3 Global Oligonucleotide API Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Oligonucleotide API Market Size YoY Growth 2016-2027
6.1.1 China Oligonucleotide API Sales YoY Growth 2016-2027
6.1.2 China Oligonucleotide API Revenue YoY Growth 2016-2027
6.1.3 China Oligonucleotide API Market Share in Global Market 2016-2027
6.2 China Oligonucleotide API Market Size by Players (International and Local Players)
6.2.1 China Top Oligonucleotide API Players by Sales (2016-2021)
6.2.2 China Top Oligonucleotide API Players by Revenue (2016-2021)
6.3 China Oligonucleotide API Historic Market Review by Type (2016-2021)
6.3.1 China Oligonucleotide API Sales Market Share by Type (2016-2021)
6.3.2 China Oligonucleotide API Revenue Market Share by Type (2016-2021)
6.3.3 China Oligonucleotide API Price by Type (2016-2021)
6.4 China Oligonucleotide API Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Oligonucleotide API Sales Forecast by Type (2022-2027)
6.4.2 China Oligonucleotide API Revenue Forecast by Type (2022-2027)
6.4.3 China Oligonucleotide API Price Forecast by Type (2022-2027)
6.5 China Oligonucleotide API Historic Market Review by Application (2016-2021)
6.5.1 China Oligonucleotide API Sales Market Share by Application (2016-2021)
6.5.2 China Oligonucleotide API Revenue Market Share by Application (2016-2021)
6.5.3 China Oligonucleotide API Price by Application (2016-2021)
6.6 China Oligonucleotide API Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Oligonucleotide API Sales Forecast by Application (2022-2027)
6.6.2 China Oligonucleotide API Revenue Forecast by Application (2022-2027)
6.6.3 China Oligonucleotide API Price Forecast by Application (2022-2027)
7 North America
7.1 North America Oligonucleotide API Market Size YoY Growth 2016-2027
7.2 North America Oligonucleotide API Market Facts & Figures by Country
7.2.1 North America Oligonucleotide API Sales by Country (2016-2021)
7.2.2 North America Oligonucleotide API Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Oligonucleotide API Market Size YoY Growth 2016-2027
8.2 Asia Pacific Oligonucleotide API Market Facts & Figures by Region
8.2.1 Asia Pacific Oligonucleotide API Sales by Region (2016-2021)
8.2.2 Asia Pacific Oligonucleotide API Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Oligonucleotide API Market Size YoY Growth 2016-2027
9.2 Europe Oligonucleotide API Market Facts & Figures by Country
9.2.1 Europe Oligonucleotide API Sales by Country (2016-2021)
9.2.2 Europe Oligonucleotide API Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Oligonucleotide API Market Size YoY Growth 2016-2027
10.2 Latin America Oligonucleotide API Market Facts & Figures by Country
10.2.1 Latin America Oligonucleotide API Sales by Country (2016-2021)
10.2.2 Latin America Oligonucleotide API Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Oligonucleotide API Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Oligonucleotide API Market Facts & Figures by Country
11.2.1 Middle East and Africa Oligonucleotide API Sales by Country (2016-2021)
11.2.2 Middle East and Africa Oligonucleotide API Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Jazz Pharmaceuticals
12.1.1 Jazz Pharmaceuticals Corporation Information
12.1.2 Jazz Pharmaceuticals Description and Business Overview
12.1.3 Jazz Pharmaceuticals Oligonucleotide API Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Jazz Pharmaceuticals Oligonucleotide API Products Offered
12.1.5 Jazz Pharmaceuticals Recent Development
12.2 Sarepta Therapeutics
12.2.1 Sarepta Therapeutics Corporation Information
12.2.2 Sarepta Therapeutics Description and Business Overview
12.2.3 Sarepta Therapeutics Oligonucleotide API Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sarepta Therapeutics Oligonucleotide API Products Offered
12.2.5 Sarepta Therapeutics Recent Development
12.3 Biogen
12.3.1 Biogen Corporation Information
12.3.2 Biogen Description and Business Overview
12.3.3 Biogen Oligonucleotide API Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Biogen Oligonucleotide API Products Offered
12.3.5 Biogen Recent Development
12.4 Dynavax Technologies
12.4.1 Dynavax Technologies Corporation Information
12.4.2 Dynavax Technologies Description and Business Overview
12.4.3 Dynavax Technologies Oligonucleotide API Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Dynavax Technologies Oligonucleotide API Products Offered
12.4.5 Dynavax Technologies Recent Development
12.5 Akcea Therapeutics
12.5.1 Akcea Therapeutics Corporation Information
12.5.2 Akcea Therapeutics Description and Business Overview
12.5.3 Akcea Therapeutics Oligonucleotide API Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Akcea Therapeutics Oligonucleotide API Products Offered
12.5.5 Akcea Therapeutics Recent Development
12.6 Alnylam Pharmaceuticals
12.6.1 Alnylam Pharmaceuticals Corporation Information
12.6.2 Alnylam Pharmaceuticals Description and Business Overview
12.6.3 Alnylam Pharmaceuticals Oligonucleotide API Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Alnylam Pharmaceuticals Oligonucleotide API Products Offered
12.6.5 Alnylam Pharmaceuticals Recent Development
12.7 Nitto Denko (Avecia)
12.7.1 Nitto Denko (Avecia) Corporation Information
12.7.2 Nitto Denko (Avecia) Description and Business Overview
12.7.3 Nitto Denko (Avecia) Oligonucleotide API Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Nitto Denko (Avecia) Oligonucleotide API Products Offered
12.7.5 Nitto Denko (Avecia) Recent Development
12.8 Ajinomoto (GeneDesign)
12.8.1 Ajinomoto (GeneDesign) Corporation Information
12.8.2 Ajinomoto (GeneDesign) Description and Business Overview
12.8.3 Ajinomoto (GeneDesign) Oligonucleotide API Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Ajinomoto (GeneDesign) Oligonucleotide API Products Offered
12.8.5 Ajinomoto (GeneDesign) Recent Development
12.9 RiboBio
12.9.1 RiboBio Corporation Information
12.9.2 RiboBio Description and Business Overview
12.9.3 RiboBio Oligonucleotide API Sales, Revenue and Gross Margin (2016-2021)
12.9.4 RiboBio Oligonucleotide API Products Offered
12.9.5 RiboBio Recent Development
12.11 Jazz Pharmaceuticals
12.11.1 Jazz Pharmaceuticals Corporation Information
12.11.2 Jazz Pharmaceuticals Description and Business Overview
12.11.3 Jazz Pharmaceuticals Oligonucleotide API Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Jazz Pharmaceuticals Oligonucleotide API Products Offered
12.11.5 Jazz Pharmaceuticals Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Oligonucleotide API Industry Trends
13.2 Oligonucleotide API Market Drivers
13.3 Oligonucleotide API Market Challenges
13.4 Oligonucleotide API Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oligonucleotide API Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Global Oligonucleotide API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Antisense Oligonucleotides API
    Table 3. Major Manufacturers of Small Interfering RNA (siRNA) API
    Table 4. Major Manufacturers of MiRNA API
    Table 5. Major Manufacturers of CpG Oligonucleotides API
    Table 6. Major Manufacturers of Others
    Table 7. Global Oligonucleotide API Market Size Growth Rate by Application (2021-2027) & (Ton)
    Table 8. Global Oligonucleotide API Market Size by Region (Ton) & (US$ Million), 2016 VS 2021 VS 2027
    Table 9. Global Oligonucleotide API Sales by Regions (2016-2021) & (Ton)
    Table 10. Global Oligonucleotide API Sales Market Share by Regions (2016-2021)
    Table 11. Global Oligonucleotide API Revenue by Regions (2016-2021) & (US$ Million)
    Table 12. Global Oligonucleotide API Sales Forecast by Region (2022-2027) & (Ton)
    Table 13. Global Oligonucleotide API Sales Market Share Forecast by Region (2022-2027)
    Table 14. Global Oligonucleotide API Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 15. Global Oligonucleotide API Revenue Market Share Forecast by Region (2022-2027)
    Table 16. Global Oligonucleotide API Sales by Manufacturers (2016-2021) (Ton)
    Table 17. Global Oligonucleotide API Sales Share by Manufacturers (2016-2021)
    Table 18. Ranking of Global Top Oligonucleotide API Manufacturers by Revenue (US$ Million) in 2020
    Table 19. Oligonucleotide API Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 20. Oligonucleotide API Revenue Share by Manufacturers (2016-2021)
    Table 21. Global Oligonucleotide API Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 22. Global Oligonucleotide API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide API as of 2020)
    Table 23. Key Manufacturers Oligonucleotide API Price (2016-2021) (US$/Ton)
    Table 24. Oligonucleotide API Manufacturers Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Oligonucleotide API Product Type
    Table 26. Date of International Manufacturers Enter into Oligonucleotide API Market
    Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 28. Global Oligonucleotide API Sales by Type (2016-2021) (Ton)
    Table 29. Global Oligonucleotide API Sales Share by Type (2016-2021)
    Table 30. Global Oligonucleotide API Revenue by Type (2016-2021) (US$ Million)
    Table 31. Global Oligonucleotide API Revenue Share by Type (2016-2021)
    Table 32. Oligonucleotide API Average Selling Price (ASP) by Type (2016-2021) & (US$/Ton)
    Table 33. Global Oligonucleotide API Sales Forecast by Type (2022-2027) & (Ton)
    Table 34. Global Oligonucleotide API Sales Market Share Forecast by Type (2022-2027)
    Table 35. Global Oligonucleotide API Revenue Forecast V (2022-2027) & (US$ Million)
    Table 36. Global Oligonucleotide API Revenue Market Share Forecast by Type (2022-2027)
    Table 37. Global Oligonucleotide API Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Ton)
    Table 38. Global Oligonucleotide API Sales by Application (2016-2021) (Ton)
    Table 39. Global Oligonucleotide API Sales Share by Application (2016-2021)
    Table 40. Global Oligonucleotide API Revenue by Application (2016-2021) (US$ Million)
    Table 41. Global Oligonucleotide API Revenue Share by Application (2016-2021)
    Table 42. Oligonucleotide API Average Selling Price (ASP) by Application (2016-2021) & (US$/Ton)
    Table 43. Global Oligonucleotide API Sales Forecast by Application (2022-2027) & (Ton)
    Table 44. Global Oligonucleotide API Sales Market Share Forecast by Application (2022-2027)
    Table 45. Global Oligonucleotide API Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 46. Global Oligonucleotide API Revenue Market Share Forecast by Application (2022-2027)
    Table 47. Global Oligonucleotide API Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Ton)
    Table 48. China Oligonucleotide API Sales (Ton) of Key Companies (2016-2021)
    Table 49. China Oligonucleotide API Sales Share by Company (2016-2021)
    Table 50. China Oligonucleotide API Revenue (US$ Million) by Company (2016-2021)
    Table 51. China Oligonucleotide API Revenue Share by Company (2016-2021)
    Table 52. China Oligonucleotide API Sales (Ton) by Type (2016-2021)
    Table 53. China Oligonucleotide API Sales Share by Type (2016-2021)
    Table 54. China Oligonucleotide API Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 55. China Oligonucleotide API Price (US$/Ton) by Type (2016-2021)
    Table 56. China Oligonucleotide API Sales (Ton) by Type (2022-2027)
    Table 57. China Oligonucleotide API Sales Share by Type (2022-2027)
    Table 58. China Oligonucleotide API Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 59. China Oligonucleotide API Revenue Share by Type (2022-2027)
    Table 60. China Oligonucleotide API Price (US$/Ton) by Type (2022-2027)
    Table 61. China Oligonucleotide API Sales (Ton) by Application (2016-2021)
    Table 62. China Oligonucleotide API Sales Share by Application (2016-2021)
    Table 63. China Oligonucleotide API Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 64. China Oligonucleotide API Price (US$/Ton) by Application (2016-2021)
    Table 65. China Oligonucleotide API Sales (Ton) by Application (2022-2027)
    Table 66. China Oligonucleotide API Sales Share by Application (2022-2027)
    Table 67. China Oligonucleotide API Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 68. China Oligonucleotide API Revenue Share by Application (2022-2027)
    Table 69. China Oligonucleotide API Price (US$/Ton) by Application (2022-2027)
    Table 70. North America Oligonucleotide API Sales by Country (2016-2021) & (Ton)
    Table 71. North America Oligonucleotide API Sales Market Share by Country (2016-2021)
    Table 72. North America Oligonucleotide API Revenue by Country (2016-2021) & (US$ Million)
    Table 73. North America Oligonucleotide API Revenue Market Share by Country (2016-2021)
    Table 74. Asia Pacific Oligonucleotide API Sales by Region (2016-2021) & (Ton)
    Table 75. Asia Pacific Oligonucleotide API Sales Market Share by Region (2016-2021)
    Table 76. Asia Pacific Oligonucleotide API Revenue by Region (2016-2021) & (US$ Million)
    Table 77. Asia Pacific Oligonucleotide API Revenue Market Share by Region (2016-2021)
    Table 78. Europe Oligonucleotide API Sales by Country (2016-2021) & (Ton)
    Table 79. Europe Oligonucleotide API Sales Market Share by Country (2016-2021)
    Table 80. Europe Oligonucleotide API Revenue by Country (2016-2021) & (US$ Million)
    Table 81. Europe Oligonucleotide API Revenue Market Share by Country (2016-2021)
    Table 82. Latin America Oligonucleotide API Sales by Country (2016-2021) & (Ton)
    Table 83. Latin America Oligonucleotide API Sales Market Share by Country (2016-2021)
    Table 84. Latin Americaa Oligonucleotide API Revenue by Country (2016-2021) & (US$ Million)
    Table 85. Latin America Oligonucleotide API Revenue Market Share by Country (2016-2021)
    Table 86. Middle East and Africa Oligonucleotide API Sales by Country (2016-2021) & (Ton)
    Table 87. Middle East and Africa Oligonucleotide API Sales Market Share by Country (2016-2021)
    Table 88. Middle East and Africa Oligonucleotide API Revenue by Country (2016-2021) & (US$ Million)
    Table 89. Middle East and Africa Oligonucleotide API Revenue Market Share by Country (2016-2021)
    Table 90. Jazz Pharmaceuticals Corporation Information
    Table 91. Jazz Pharmaceuticals Description and Business Overview
    Table 92. Jazz Pharmaceuticals Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 93. Jazz Pharmaceuticals Oligonucleotide API Product
    Table 94. Jazz Pharmaceuticals Recent Development
    Table 95. Sarepta Therapeutics Corporation Information
    Table 96. Sarepta Therapeutics Description and Business Overview
    Table 97. Sarepta Therapeutics Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 98. Sarepta Therapeutics Product
    Table 99. Sarepta Therapeutics Recent Development
    Table 100. Biogen Corporation Information
    Table 101. Biogen Description and Business Overview
    Table 102. Biogen Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 103. Biogen Product
    Table 104. Biogen Recent Development
    Table 105. Dynavax Technologies Corporation Information
    Table 106. Dynavax Technologies Description and Business Overview
    Table 107. Dynavax Technologies Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 108. Dynavax Technologies Product
    Table 109. Dynavax Technologies Recent Development
    Table 110. Akcea Therapeutics Corporation Information
    Table 111. Akcea Therapeutics Description and Business Overview
    Table 112. Akcea Therapeutics Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 113. Akcea Therapeutics Product
    Table 114. Akcea Therapeutics Recent Development
    Table 115. Alnylam Pharmaceuticals Corporation Information
    Table 116. Alnylam Pharmaceuticals Description and Business Overview
    Table 117. Alnylam Pharmaceuticals Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 118. Alnylam Pharmaceuticals Product
    Table 119. Alnylam Pharmaceuticals Recent Development
    Table 120. Nitto Denko (Avecia) Corporation Information
    Table 121. Nitto Denko (Avecia) Description and Business Overview
    Table 122. Nitto Denko (Avecia) Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 123. Nitto Denko (Avecia) Product
    Table 124. Nitto Denko (Avecia) Recent Development
    Table 125. Ajinomoto (GeneDesign) Corporation Information
    Table 126. Ajinomoto (GeneDesign) Description and Business Overview
    Table 127. Ajinomoto (GeneDesign) Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 128. Ajinomoto (GeneDesign) Product
    Table 129. Ajinomoto (GeneDesign) Recent Development
    Table 130. RiboBio Corporation Information
    Table 131. RiboBio Description and Business Overview
    Table 132. RiboBio Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
    Table 133. RiboBio Product
    Table 134. RiboBio Recent Development
    Table 135. Oligonucleotide API Market Trends
    Table 136. Oligonucleotide API Market Drivers
    Table 137. Oligonucleotide API Market Challenges
    Table 138. Oligonucleotide API Market Restraints
    Table 139. Oligonucleotide API Customers List
    Table 140. Oligonucleotide API Distributors List
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oligonucleotide API Product Picture
    Figure 2. Global Oligonucleotide API Sales Market Share by Type in 2020 & 2027
    Figure 3. Antisense Oligonucleotides API Product Picture
    Figure 4. Small Interfering RNA (siRNA) API Product Picture
    Figure 5. MiRNA API Product Picture
    Figure 6. CpG Oligonucleotides API Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Oligonucleotide API Sales Market Share by Application in 2020 & 2027
    Figure 9. Contract Manufacturing Organizations (CMOs)
    Figure 10. Pharmaceutical Companies
    Figure 11. Oligonucleotide API Report Years Considered
    Figure 12. Global Oligonucleotide API Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Oligonucleotide API Market Size 2016-2027 (US$ Million)
    Figure 14. Global Oligonucleotide API Sales 2016-2027 (Ton)
    Figure 15. Global Oligonucleotide API Market Size Market Share by Region: 2021 Versus 2027
    Figure 16. Global Oligonucleotide API Sales Market Share by Region (2016-2021)
    Figure 17. Global Oligonucleotide API Sales Market Share by Region in 2020
    Figure 18. Global Oligonucleotide API Revenue Market Share by Region (2016-2021)
    Figure 19. Global Oligonucleotide API Revenue Market Share by Region in 2020
    Figure 20. Global Oligonucleotide API Sales Share by Manufacturer in 2020
    Figure 21. The Top 10 and 5 Players Market Share by Oligonucleotide API Revenue in 2020
    Figure 22. Oligonucleotide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 23. Global Oligonucleotide API Sales Market Share by Type (2016-2021)
    Figure 24. Global Oligonucleotide API Sales Market Share by Type in 2020
    Figure 25. Global Oligonucleotide API Revenue Market Share by Type (2016-2021)
    Figure 26. Global Oligonucleotide API Revenue Market Share by Type in 2020
    Figure 27. Global Oligonucleotide API Sales Market Share by Application (2016-2021)
    Figure 28. Global Oligonucleotide API Sales Market Share by Application in 2020
    Figure 29. Global Oligonucleotide API Revenue Market Share by Application (2016-2021)
    Figure 30. Global Oligonucleotide API Revenue Market Share by Application in 2020
    Figure 31. China Oligonucleotide API Sales Growth Rate 2016-2027 (Ton)
    Figure 32. China Oligonucleotide API Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 33. China Oligonucleotide API Market Share in Global Market 2016-2027
    Figure 34. China 5 and 10 Largest Oligonucleotide API Players Market Share by Revenue in Oligonucleotide API in 2020
    Figure 35. China Oligonucleotide API Revenue Share by Type (2016-2021)
    Figure 36. China Oligonucleotide API Revenue Growth Rate by Type in 2016 & 2020
    Figure 37. China Oligonucleotide API Revenue Share by Application (2016-2021)
    Figure 38. China Oligonucleotide API Revenue Growth Rate by Application in 2016 & 2020
    Figure 39. North America Oligonucleotide API Sales Growth Rate 2016-2021 (Ton)
    Figure 40. North America Oligonucleotide API Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 41. North America Oligonucleotide API Sales Market Share by Country in 2020
    Figure 42. North America Oligonucleotide API Revenue Market Share by Country in 2020
    Figure 43. U.S. Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 44. U.S. Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Canada Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 46. Canada Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 47. Europe Oligonucleotide API Sales Growth Rate 2016-2021 (Ton)
    Figure 48. Europe Oligonucleotide API Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 49. Europe Oligonucleotide API Sales Market Share by Country in 2020
    Figure 50. Europe Oligonucleotide API Revenue Market Share by Country in 2020
    Figure 51. Germany Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 52. Germany Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 53. France Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 54. France Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 55. U.K. Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 56. U.K. Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 57. Italy Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 58. Italy Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 59. Russia Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 60. Russia Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 61. Asia Pacific Oligonucleotide API Sales Growth Rate 2016-2021 (Ton)
    Figure 62. Asia Pacific Oligonucleotide API Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 63. Asia Pacific Oligonucleotide API Sales Market Share by Region in 2020
    Figure 64. Asia Pacific Oligonucleotide API Revenue Market Share by Region in 2020
    Figure 65. China Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 66. China Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 67. Japan Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 68. Japan Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 69. South Korea Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 70. South Korea Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 71. India Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 72. India Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 73. Australia Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 74. Australia Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 75. Taiwan Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 76. Taiwan Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 77. Indonesia Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 78. Indonesia Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 79. Thailand Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 80. Thailand Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 81. Malaysia Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 82. Malaysia Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 83. Philippines Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 84. Philippines Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 85. Vietnam Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 86. Vietnam Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 87. Latin America Oligonucleotide API Sales Growth Rate 2016-2021 (Ton)
    Figure 88. Latin America Oligonucleotide API Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 89. Latin America Oligonucleotide API Sales Market Share by Country in 2020
    Figure 90. Latin America Oligonucleotide API Revenue Market Share by Country in 2020
    Figure 91. Mexico Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 92. Mexico Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 93. Brazil Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 94. Brazil Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 95. Argentina Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 96. Argentina Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 97. Middle East and Africa Oligonucleotide API Sales Growth Rate 2016-2021 (Ton)
    Figure 98. Middle East and Africa Oligonucleotide API Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 99. Middle East and Africa Oligonucleotide API Sales Market Share by Country in 2020
    Figure 100. Middle East and Africa Oligonucleotide API Revenue Market Share by Country in 2020
    Figure 101. Turkey Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 102. Turkey Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 103. Saudi Arabia Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 104. Saudi Arabia Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 105. UAE Oligonucleotide API Sales Growth Rate (2016-2021) (Ton)
    Figure 106. UAE Oligonucleotide API Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 107. Oligonucleotide API Value Chain
    Figure 108. Channels of Distribution
    Figure 109. Distributors Profiles
    Figure 110. Bottom-up and Top-down Approaches for This Report
    Figure 111. Data Triangulation
    Figure 112. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global PCR Reagent Market Insights and Forecast to 2028
Global PCR Reagent Market Insights and Forecast to 2028

Market Analysis and Insights Global PCR Reagent MarketDue to the COVID19 pandemic the global PCR Reagent market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-28A9097
Wed Jan 19 00:00:00 UTC 2022

Add to Cart

Global Small Molecule Cancer Drug Market Insights and Forecast to 2028
Global Small Molecule Cancer Drug Market Insights and Forecast to 2028

Market Analysis and Insights Global Small Molecule Cancer Drug MarketDue to the COVID19 pandemic the global Small Molecule Cancer Drug market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-2V9651
Wed Jan 19 00:00:00 UTC 2022

Add to Cart

Global Chimeric Antibody Market Insights and Forecast to 2028
Global Chimeric Antibody Market Insights and Forecast to 2028

Because it reduces the murine component it reduces the adverse reactions caused by murine antibody and helps to improve the curative effect.Market Analysis and Insights Global Chimeric Antibody MarketThe global Chimeric Antibody market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis IgG accounting for of the Chimeric Antibody global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

120 Pages
Type: Report
Code: QYRE-Auto-14S9314
Wed Jan 19 00:00:00 UTC 2022

Add to Cart

Global Doramectin Market Insights and Forecast to 2028
Global Doramectin Market Insights and Forecast to 2028

The main function is to treat domestic animal nematode disease blood lice acaricosis and other ectoparasites.Market Analysis and Insights Global Doramectin MarketDue to the COVID19 pandemic the global Doramectin market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-29L9128
Wed Jan 19 00:00:00 UTC 2022

Add to Cart